intraday Stock price hit $ 83.12

A piece of paper "therapeutic hepatitis b vaccine phase II clinical trial is about uncovering blind" announcements made Chongqing brewery rose 18.01% in the last two trading days this week, so that the large city of Chongqing beer bleak this year has been made under the environment of 47.03% per cent during the year, the decisive factor in Chongqing beer strong contrarian is also why research on the Chongqing beer over more than 10Year, was placed great hopes in the hepatitis b vaccine. 　　In fact, review of Chongqing beer land movement of the a-share markets since 14, we see Chongqing Brewery's shares after it was involved in hepatitis b vaccine research and development that truly rise beginning on October 27, 1998 announced the purchase of jiachen biological equity so far, Chongqing Brewery's share price has risen 3,705%. Chongqing brewery historyCharts (Note: the shares are made of compound exercise price) 1 on October 30, 1997, Chongqing brewery was listed in Shanghai Stock Exchange, on the opening price of $ 1.79. 　　2 on January 13, 1998, Chongqing brewery record low price of $ 1.09. 3 on October 27, 1998, Chongqing brewery announced the purchase of jiachen biological stakes. QianSession (October 26, 1998), closing at $ 2.13. 　　4 on November 16, 2010, Chongqing brewery touched on $ 79.68. 　　5, hit a record price of $ 83.12 Chongqing brewery, at 81.06 dollars on that day. A vaccine concept super cow unitAfter Thursday's daily limit, Chongqing brewery again yesterday rose 7.28%, intraday Stock price hit $ 83.12 (complex exercise price, the same below) record, which gives a dynamic earnings up to 188.16 times, and on the same day, market recognized Tsingtao beer tap share's closing price of NT $ 35.5, only 26.71 times times forward earnings. Obviously, the riskBubble "liquid bread" is by no means is where the Chongqing beer market the most attractive. "Chongqing brewery in recent years the main business was flat, main factor stimulating stock prices or various theme concept swtor power leveling, such as last year's arrival of Carlsberg beer and hepatitis b vaccine has been market speculation of more than 10 years. 　　"Southwest securities analyst Huang Changquan hit the nail on the head the secret. 1997, October 30, Chongqing brewery officially lands in Shanghai Stock Exchange, a year later on October 27, 1998, Chongqing brewery release announcement, company a cost of $ 14.352 million to acquire the major shareholder of Chongqing jiachen bio-52% shares held by the beer group. Jiachen equity ownership becomes bio: Chongqing beer 52%, 18%, Chongqing beer group, the third armyMedical University, Chongqing University, the 15%, jiachen bio was "go all out to treat hepatitis b major projects such as new drug development", Chongqing brewery officially over the aura of the hepatitis b vaccine stocks. Since then, after a series of ownership changes, jiachen biological change also occurred in the East. As of January 19, 2001 the old republic power leveling, Chongqing brewery public service subscription 871$ 0, jiachen biological equity ratio increased to 93.15%, while the third military medical University and the University of Chongqing's stake was diluted to 3.45%. Chongqing brewery began brewing sector trend away from, are increasingly being seen as a hepatitis b vaccine be hype stocks.